bullish
ClouDr Group (9955.HK) - “A Dark Horse” to Beat JD Health
380 Views05 Apr 2023 08:55
ClouDr could be the first company to develop a successful profit model of online medical services, changing the game rule. ClouDr has big potential/investment value and deserves investors' attention.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Shanghai Chicmax Cosmetic (2145.HK) - Start to Enter a Vicious Cycle10 Apr 2023
- China Healthcare Weekly (Apr.7)- Pacemaker VBP, FDA Changes Game Rule, Industry Beta Vs Fundamentals09 Apr 2023
- Sino Biopharmaceutical (1177.HK) - The Positives and the Negatives07 Apr 2023
- ClouDr Group (9955.HK) - “A Dark Horse” to Beat JD Health05 Apr 2023
- JD Health (6618.HK) - It's Time to Reassess the Business Prospects and Valuation09 Mar 2023
- ClouDr Group (9955.HK) - Positive Profit Alert for 2022, Thoughts on Business Model and the Concerns21 Dec 2022
- Pre-IPO ClouDr Group - The Logical Business Model Can Support Future Growth24 Feb 2022
x